Merck
  • Home
  • Search Results
  • Evidence of a Viable Pool of Stem Cells within Human Osteoarthritic Cartilage.

Evidence of a Viable Pool of Stem Cells within Human Osteoarthritic Cartilage.

Cartilage (2015-06-13)
Larissa Nelson, Helen E McCarthy, John Fairclough, Rebecca Williams, Charles W Archer
ABSTRACT

Osteoarthritis (OA) is a debilitating disease affecting more than 4 million people in the United Kingdom. Despite its prevalence, there is no successful cell-based therapy currently used to treat patients whose cartilage is deemed irrecoverable. The present study aimed to isolate stem cells from tibial plateaux cartilage obtained from patients who underwent total knee replacements for OA and investigate their stem cell characteristics. Clonally derived cell lines were selected using a differential adhesion assay to fibronectin and expanded in monolayer culture. Colony forming efficiencies and growth kinetics were investigated. The potential for tri-lineage differentiation into chondrogenic, osteogenic, and adipogenic phenotypes were analyzed using histological stains, immunocytochemistry, and reverse transcriptase polymerase chain reaction. Colony forming cells were successfully isolated from osteoarthritic cartilage and extensively expanded in monolayer culture. Colony forming efficiencies were consistently below 0.1%. Clonal cell lines were expanded beyond 40 population doublings but disparities were observed in the number of population doublings per day. Clonally derived cell lines also demonstrated in vitro multilineage potential via successful differentiation into chondrogenic, osteogenic, and adipogenic lineages. However, variation in the degree of differentiation was observed between these clonal cell lines. A viable pool of cells with stem cell characteristics have been identified within human osteoarthritic cartilage. Variation in the degree of differentiation suggests the possibility of further subpopulations of cells. The identification of this stem cell population highlights the reparative potential of these cells in osteoarthritic cartilage, which could be further exploited to aid the field of regenerative medicine.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
HEPES, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
デキサメタゾン, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
L-アスコルビン酸, 99%
Sigma-Aldrich
L-アスコルビン酸, powder, suitable for cell culture, γ-irradiated
Supelco
アスコルビン酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-アスコルビン酸, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
L-グルタミン, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-アスコルビン酸, ACS reagent, ≥99%
Sigma-Aldrich
デキサメタゾン, ≥98% (HPLC), powder
Sigma-Aldrich
HEPES緩衝液, 1 M in H2O
Sigma-Aldrich
L-アスコルビン酸, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
L-グルタミン, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
セレン, powder, −100 mesh, 99.99% trace metals basis
Sigma-Aldrich
L-アスコルビン酸, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
SAFC
HEPES
SAFC
L-グルタミン
Supelco
デキサメタゾン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-アスコルビン酸, reagent grade, crystalline
Sigma-Aldrich
セレン, powder, −100 mesh, ≥99.5% trace metals basis
Sigma-Aldrich
HEPES, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
3,3′-ジアミノベンジジン, ≥97% (HPLC)
USP
アスコルビン酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
L-アスコルビン酸, meets USP testing specifications
Sigma-Aldrich
HEPES, BioXtra, pH 5.0-6.5 (1 M in H2O), ≥99.5% (titration)
Sigma-Aldrich
3,3′-ジアミノベンジジン, 98%
Sigma-Aldrich
L-(−)-グルコース, ≥99%
SAFC
HEPES
Supelco
L-アスコルビン酸, analytical standard
Sigma-Aldrich
L-アスコルビン酸, reagent grade